<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03348189</url>
  </required_header>
  <id_info>
    <org_study_id>QATP3093</org_study_id>
    <nct_id>NCT03348189</nct_id>
  </id_info>
  <brief_title>SpO2 Hypoxia Accuracy Validation Study</brief_title>
  <official_title>SpO2 Hypoxia Accuracy Validation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nonin Medical, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nonin Medical, Inc</source>
  <oversight_info>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate the % oxygen saturation by pulse oximetry&#xD;
      accuracy of a combined pulse oximetry system which consists of a Nonin sensor ), an adaptor&#xD;
      cable, and an oximetry system during non-motion conditions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to evaluate the %SpO2 accuracy of a combined pulse&#xD;
      oximetry system which consists of a Nonin sensor ), an adaptor cable, and an oximetry system&#xD;
      during non-motion conditions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Actual">November 3, 2017</completion_date>
  <primary_completion_date type="Actual">November 3, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SpO2 Hypoxia Accuracy Validation Study</measure>
    <time_frame>Through study completion, 3 months average</time_frame>
    <description>Values from the test device will be compared to the values from co-oximetry to determine accuracy of the test device.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">12</enrollment>
  <condition>Hypoxia</condition>
  <arm_group>
    <arm_group_label>Observational</arm_group_label>
    <description>Healthy males and females</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pulse Oximeter</intervention_name>
    <description>Pulse Oximeter</description>
    <arm_group_label>Observational</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A minimum of 12 subjects will be enrolled. The subject population will include both male&#xD;
        and female subjects with a variety of skin tones.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The subject is male or female&#xD;
&#xD;
          -  The subject is of any racial or ethnic group&#xD;
&#xD;
          -  The subject is ≥ 30 kg (≥ 66 pounds) in weight (self-reported)&#xD;
&#xD;
          -  The subject has at least one finger height of 0.2 - 1.0 inch (based on measurement)&#xD;
&#xD;
          -  The subject is between 18 years and 50 years of age (self-reported)&#xD;
&#xD;
          -  The subject shows no evidence of medical problems as indicated by satisfactory&#xD;
             completion of the health assessment form&#xD;
&#xD;
          -  The subject has given written informed consent to participate in the study&#xD;
&#xD;
          -  The subject is both willing and able to comply with study procedures.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The subject has a BMI greater than 31 (based on weight and height)&#xD;
&#xD;
          -  The subject has had any relevant injury at the sensor location site (self-reported)&#xD;
&#xD;
          -  The subject has deformities or abnormalities that may prevent proper application of&#xD;
             the device under test (based on examination)&#xD;
&#xD;
          -  The subject is current smoker (self-reported)&#xD;
&#xD;
          -  The subject has a known respiratory condition (self-reported)&#xD;
&#xD;
          -  The subject has a known heart or cardiovascular condition (self-reported)&#xD;
&#xD;
          -  The subject is currently pregnant, is actively trying to get pregnant, or who has a&#xD;
             positive urine pregnancy test on the day of the study&#xD;
&#xD;
          -  The subject has a clotting disorder (self-reported)&#xD;
&#xD;
          -  The subject has Raynaud's Disease (self-reported)&#xD;
&#xD;
          -  The subject is known to have a hemoglobinopathy (self-reported)&#xD;
&#xD;
          -  The subject is on blood thinners or medication with aspirin (self-reported)&#xD;
&#xD;
          -  The subject has unacceptable collateral circulation from the ulnar artery (based on&#xD;
             examination)&#xD;
&#xD;
          -  The subject is unwilling or unable to provide written informed consent to participate&#xD;
             in the study&#xD;
&#xD;
          -  The subject is unwilling or unable to comply with the study procedures&#xD;
&#xD;
          -  The subject has another health condition which in the opinion of the principal&#xD;
             investigator makes him/her unsuitable for testing.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dena Raley</last_name>
    <role>Study Director</role>
    <affiliation>Clinimark, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinimark</name>
      <address>
        <city>Louisville</city>
        <state>Colorado</state>
        <zip>80027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>November 15, 2017</study_first_submitted>
  <study_first_submitted_qc>November 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2017</study_first_posted>
  <last_update_submitted>November 15, 2017</last_update_submitted>
  <last_update_submitted_qc>November 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

